Dr. William Margolin's lab at the University of Texas Health Science Center focuses on understanding how bacteria like E. coli manage to grow and divide. By studying the proteins that form their division machinery, the lab aims to uncover new insights into bacterial cell function and identify potential targets for new antibiotics. Their work combines advanced imaging techniques and molecular genetics to explore the mechanical processes in bacterial life.

Dr. Suzanne Walker's lab at Harvard Medical School focuses on understanding bacterial cell envelopes and their roles in antibiotic resistance. The team investigates how bacteria maintain their structural integrity and how this knowledge can aid in developing new antibiotics. By exploring the molecular mechanisms behind cell envelope biogenesis, the lab aims to identify new therapeutic targets to combat resistant bacterial infections.

Dr. Alexander Poltorak's lab at Tufts University studies how the body responds to bacterial infections, specifically focusing on a protein called ZBP1. They explore how ZBP1 influences cell death and inflammation in response to lipopolysaccharides (LPS), which are components of bacterial cell membranes. Their research aims to uncover new pathways in the immune response and identify potential therapeutic targets to improve treatments for infections.

Dr. Kim Davis's lab focuses on understanding how certain bacteria survive antibiotic treatment within the human body. These survival strategies can lead to relapsing infections, which are a growing public health concern. The lab uses a mouse model to study how bacteria interact with immune cells and how these interactions help them persist during antibiotic therapy. The ultimate goal is to find new ways to improve antibiotic treatments and combat these persistent infections.

Dr. Eduardo Groisman's lab at Yale University studies how bacteria manage their proteins to survive and cause disease. They focus on the mechanisms bacteria use to control protein levels and how this affects their ability to infect hosts and resist antibiotics. Their research has important implications for understanding bacterial infections and developing new treatment strategies.

Dr. Som Chatterjee's lab at the University of Maryland Baltimore focuses on understanding how certain bacterial proteins enable Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), to resist common antibiotics called beta-lactams. The research explores a specific signaling pathway involving serine/threonine kinases that influence the bacteria's resistance mechanisms, aiming to identify new treatment options for these difficult infections. This work combines molecular biology techniques with genetic studies to uncover novel strategies for combating antibiotic resistance.

Professor Joel G. Belasco's lab at New York University School of Medicine focuses on understanding how bacterial messenger RNA (mRNA) is degraded. This research is crucial for determining how gene expression is regulated in bacteria, especially in relation to their pathogenesis and response to antibiotics. The lab investigates unique RNA modifications and uses various molecular techniques to uncover how these processes affect bacteria in different environments.

Dr. Mario Feldman's lab at Washington University focuses on understanding how bacteria, particularly those that are resistant to antibiotics, respond to stress and interact with the human body. One project looks at how the bacterium Acinetobacter baumannii manages stress through a novel biochemical pathway, which could have implications for treating infections. Another project investigates outer membrane vesicles produced by gut bacteria, which may play a role in maintaining gut health and influencing immune responses. Overall, the lab aims to uncover new molecular mechanisms that could lead to better treatments for bacterial infections and improve our understanding of gut microbiology.

Dr. John D. Helmann's lab at Cornell University studies how bacteria, specifically Bacillus subtilis, respond to stress from both nutrients and antibiotics. They investigate how bacteria manage essential metal ions in the presence of immune responses and how they develop resistance to antibiotics. Their findings contribute to our understanding of bacterial behavior in health and disease, which can help in developing better treatments against pathogenic bacteria.

Dr. Karla J. F. Satchell's lab at Northwestern University studies how certain bacterial toxins influence the infection process. Specifically, they focus on MARTX toxins from Vibrio bacteria, which deliver several effector proteins at once to manipulate host cell signaling and enhance bacterial virulence. By understanding the interactions between these effector proteins, the lab aims to uncover new strategies that might help combat infections caused by these harmful bacteria.

David A Dubnau's lab at Rutgers Biomedical and Health Sciences focuses on understanding how bacteria can take up DNA from their environment, a process that can lead to antibiotic resistance and other traits. The lab studies the detailed mechanisms involved in this transformation process using the bacterium Bacillus subtilis as a model system. Researchers employ a variety of biochemical and biophysical methods to investigate the proteins and processes that facilitate this uptake and integration of DNA into bacterial genomes.

Dr. Susan C. Baker's lab at Loyola University Chicago focuses on understanding how coronaviruses, specifically SARS-CoV-2, evade the immune system. The research investigates the role of viral proteins, called interferon antagonists, in delaying the immune response, which helps the virus replicate without being detected by the host’s defenses. The team's ultimate goal is to pave the way for new antiviral therapies and vaccines against COVID-19 and other emerging coronaviruses.

Dr. Mariette Barbier's lab at West Virginia University focuses on developing new therapeutic antibodies to combat infections caused by Pseudomonas aeruginosa, especially those that are resistant to multiple drugs. They are working on a unique antibody cocktail that targets a specific component of the bacterial cell wall called lipopolysaccharide, with the hope of improving treatment options for hard-to-treat infections. Through their research, they aim to better understand how these antibodies work and provide essential data to support innovative therapies for patients.

Dr. Uttiya Basu's lab focuses on understanding how B cells, which are crucial for our immune system, diversify antibodies to fight infections. The lab is exploring the role of non-coding RNAs and specific protein complexes that help organize and modify the DNA in B cells during their development. Understanding these processes is important because mistakes in them can lead to immune deficiencies and cancers.

Dr. Jeffrey Michael Bethony's lab at George Washington University focuses on improving understanding and treatment of anal cancer, particularly as it relates to individuals living with HIV. His team manages the AIDS and Cancer Specimen Resource, which collects and distributes a large number of biospecimens for research. The goal is to enhance screening, prevention, and treatment protocols through careful analysis of specimen data, ultimately benefiting public health initiatives related to HPV-associated cancers.

Dr. Helen M. Blau's lab at Stanford University focuses on understanding how aging affects muscle stem cells (MuSCs), which are crucial for muscle repair and regeneration. With the aging population facing challenges like sarcopenia, the lab investigates the mechanisms behind the decline in MuSC function and aims to enhance muscle regeneration through innovative technologies. The research combines cutting-edge single-cell analysis and in vivo experiments to uncover new therapeutic strategies to improve muscle health in elderly individuals.

Dr. James B Bliska's lab at Dartmouth College studies how certain bacterial proteins can help pathogens avoid detection and destabilize the body's immune defenses. They focus on understanding how bacteria, like Yersinia, use specialized mechanisms to disrupt protective pathways in immune cells during infection. This research not only enhances our understanding of bacterial infections but also aims to inform new approaches to boost immune defenses against such pathogens.

Dr. Jennifer Melinda Bomberger's lab at Dartmouth College focuses on understanding the interactions between bacteria and viruses in the context of cystic fibrosis. By studying how Pseudomonas aeruginosa, a harmful bacterium, survives and causes disease in the lungs of cystic fibrosis patients, the lab aims to uncover mechanisms that promote bacterial persistence and chronic infections. Their work could lead to new therapeutic strategies to combat these severe infections.

The research lab led by Joseph Bondy-Denomy at UCSF focuses on understanding how bacteria resist infection by bacteriophages, which are viruses that specifically target bacteria. By employing advanced genetic and proteomic techniques, the lab aims to identify bacterial vulnerabilities that could be exploited to improve phage therapy, especially in the context of antibiotic resistance. This work is particularly relevant in the fight against antibiotic-resistant infections, as it seeks to develop new therapeutic strategies that harness the power of these viral predators.

Dr. Jeremy M. Boss's lab focuses on understanding how B cells, which are crucial for the immune response, decide between becoming antibody-secreting cells or memory B cells. By examining the transcriptional and epigenetic mechanisms involved in this decision-making process, the lab aims to uncover the pathways that inform these fates. This research is important for developing effective vaccines and immune therapies, especially in the context of emerging infectious diseases like COVID-19.